← All trials
NCT05895955
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 4, 2023
- Primary completion
- Jun 30, 2024
- Completion date
- Jun 30, 2025
- First posted
- Jun 9, 2023
- Last posted
- Dec 14, 2023
- Enrollment
- 290
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mahidol UniversityLead sponsor
- Mahidol UniversityReponsible party - principal investigator
- Mahidol UniversityOverall official - principal investigator
- Mahidol UniversityOfficial
- Mahidol UniversitySponsor investigator
- The Government Pharmaceutical OrganizationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.